Ecolab Valuation
Is ECL * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ECL * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ECL * (MX$3880.18) is trading above our estimate of fair value (MX$2301.37)
Significantly Below Fair Value: ECL * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ECL *?
Other financial metrics that can be useful for relative valuation.
What is ECL *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$66.91b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 4.8x |
Enterprise Value/EBITDA | 22.8x |
PEG Ratio | 3.5x |
Price to Earnings Ratio vs Peers
How does ECL *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 30.6x | ||
GMEXICO B Grupo México. de | 15.1x | 5.9% | Mex$811.4b |
SHW Sherwin-Williams | 32x | 7.4% | US$77.3b |
CEMEX CPO CEMEX. de | 52.4x | 32.3% | Mex$184.3b |
4063 Shin-Etsu Chemical | 22.8x | 10.8% | JP¥11.9t |
ECL * Ecolab | 43.1x | 12.5% | Mex$66.9b |
Price-To-Earnings vs Peers: ECL * is expensive based on its Price-To-Earnings Ratio (43.1x) compared to the peer average (30.5x).
Price to Earnings Ratio vs Industry
How does ECL *'s PE Ratio compare vs other companies in the Global Chemicals Industry?
Price-To-Earnings vs Industry: ECL * is expensive based on its Price-To-Earnings Ratio (43.1x) compared to the Global Chemicals industry average (21.7x).
Price to Earnings Ratio vs Fair Ratio
What is ECL *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 43.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ECL *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$3,880.18 | Mex$4,032.05 +3.9% | 7.2% | Mex$4,517.88 | Mex$3,346.58 | n/a | 21 |
May ’25 | Mex$3,777.00 | Mex$4,019.50 +6.4% | 9.5% | Mex$4,577.79 | Mex$3,063.20 | n/a | 22 |
Apr ’25 | n/a | Mex$3,721.95 0% | 7.9% | Mex$4,306.67 | Mex$2,981.54 | n/a | 20 |
Mar ’25 | Mex$3,842.90 | Mex$3,876.16 +0.9% | 7.7% | Mex$4,445.53 | Mex$3,077.68 | n/a | 20 |
Feb ’25 | Mex$3,440.03 | Mex$3,538.75 +2.9% | 8.4% | Mex$4,135.63 | Mex$3,101.72 | n/a | 21 |
Jan ’25 | n/a | Mex$3,412.34 0% | 7.5% | Mex$4,087.75 | Mex$3,065.81 | n/a | 22 |
Dec ’24 | Mex$3,210.11 | Mex$3,389.05 +5.6% | 5.9% | Mex$3,697.36 | Mex$3,095.46 | n/a | 22 |
Nov ’24 | n/a | Mex$3,484.93 0% | 5.6% | Mex$3,829.64 | Mex$3,206.21 | n/a | 21 |
Oct ’24 | n/a | Mex$3,388.33 0% | 5.4% | Mex$3,756.15 | Mex$3,073.21 | n/a | 21 |
Sep ’24 | n/a | Mex$3,386.87 0% | 6.3% | Mex$3,760.09 | Mex$2,905.52 | n/a | 22 |
Aug ’24 | Mex$3,135.99 | Mex$3,226.13 +2.9% | 8.1% | Mex$3,591.46 | Mex$2,782.11 | n/a | 21 |
Jul ’24 | n/a | Mex$3,134.12 0% | 7.0% | Mex$3,648.82 | Mex$2,792.29 | n/a | 22 |
Jun ’24 | n/a | Mex$3,237.82 0% | 7.2% | Mex$3,767.63 | Mex$2,883.21 | n/a | 21 |
May ’24 | Mex$2,987.10 | Mex$3,108.41 +4.1% | 8.2% | Mex$3,786.76 | Mex$2,614.67 | Mex$3,777.00 | 21 |
Apr ’24 | n/a | Mex$3,209.02 0% | 7.9% | Mex$3,910.41 | Mex$2,700.05 | n/a | 21 |
Mar ’24 | n/a | Mex$3,160.65 0% | 7.9% | Mex$3,866.08 | Mex$2,669.44 | Mex$3,842.90 | 22 |
Feb ’24 | Mex$2,839.00 | Mex$3,088.81 +8.8% | 10.0% | Mex$3,941.45 | Mex$2,533.79 | Mex$3,440.03 | 21 |
Jan ’24 | Mex$2,806.11 | Mex$3,247.76 +15.7% | 10.3% | Mex$4,157.45 | Mex$2,672.65 | n/a | 20 |
Dec ’23 | Mex$2,885.00 | Mex$3,175.32 +10.1% | 11.4% | Mex$4,112.35 | Mex$2,643.65 | Mex$3,210.11 | 20 |
Nov ’23 | n/a | Mex$3,402.67 0% | 9.6% | Mex$4,141.18 | Mex$2,760.79 | n/a | 20 |
Oct ’23 | n/a | Mex$3,674.80 0% | 5.9% | Mex$4,328.60 | Mex$3,382.34 | n/a | 19 |
Sep ’23 | n/a | Mex$3,671.70 0% | 6.1% | Mex$4,332.16 | Mex$3,385.13 | n/a | 18 |
Aug ’23 | Mex$3,271.91 | Mex$3,723.90 +13.8% | 6.4% | Mex$4,380.39 | Mex$3,422.82 | Mex$3,135.99 | 18 |
Jul ’23 | Mex$3,039.84 | Mex$3,899.11 +28.3% | 6.4% | Mex$4,529.03 | Mex$3,421.93 | n/a | 17 |
Jun ’23 | Mex$3,149.19 | Mex$3,820.55 +21.3% | 6.3% | Mex$4,428.36 | Mex$3,345.87 | n/a | 17 |
May ’23 | Mex$3,511.23 | Mex$4,002.47 +14.0% | 6.2% | Mex$4,590.54 | Mex$3,468.41 | Mex$2,987.10 | 17 |
Analyst Forecast: Target price is less than 20% higher than the current share price.